Overview / Abstract: |
Recent efforts to improve provider-patient communication and facilitate shared decision-making regarding treatments have been successful, as two-thirds of idiopathic pulmonary fibrosis (IPF) patients report being involved in discussions regarding their care. However, opportunities still exist to ensure alignment of patient and physician priorities and to provide clinicians with the most up-to-date evidence on IPF treatment options. New studies have revealed an increase in patient survival when taking either of the FDA-approved agents to treat IPF, highlighting an important need for early diagnosis and referral to IPF specialty treatment centers. |
Expiration |
Feb 09, 2019 |
Discipline(s) |
Nursing CNE, Physician CME, Physician Assistant CME, Radiology / RAD Tech CE |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.0 AMA PRA Category 1 CreditTM |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Imre Noth, MD Mary M. Salvatore, MD, MBA |
Activity Specialities / Related Topics |
Pulmonary Medicine / COPD, Pathology |
Sponsors / Supporters / Grant Providers |
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. |
Keywords / Search Terms |
Rockpointe Free CME, CME, Free CE, IPF, Idiopathic pulmonary fibrosis, Registered Nurse, Nurse Practitioner, Physician Free CE CME |